Filing Details
- Accession Number:
- 0001127602-20-028306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 09:06:09
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-06 09:06:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791393 | R Paul Kirchgraber | 531 South Spring Street Burlington NC 27215 | Ceo, Covance Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-04 | 1,500 | $214.14 | 7,698 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
